Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)
0.9996
+0.2585 (34.88%)
NASDAQ · Last Trade: Jul 29th, 6:21 PM EDT
Detailed Quote
Previous Close
0.7411
Open
1.560
Bid
0.8707
Ask
0.8800
Day's Range
0.9700 - 2.310
52 Week Range
0.4519 - 7.200
Volume
99,070,617
Market Cap
44.76M
PE Ratio (TTM)
-0.2074
EPS (TTM)
-4.8
Dividend & Yield
N/A (N/A)
1 Month Average Volume
297,720
Chart
About Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)
Salarius Pharmaceuticals is a clinical-stage biotechnology company focused on developing innovative therapies for cancer patients. The company specializes in the research and development of novel drug candidates that target specific epigenetic mechanisms to combat various forms of cancer. By harnessing the potential of these targeted therapies, Salarius aims to improve treatment outcomes and minimize side effects for patients. The company's approach emphasizes precision medicine, with a commitment to addressing unmet medical needs in oncology through robust scientific innovation and clinical trials. Read More
Specificity Inc. (OTCID: SPTY), a next-generation digital marketing firm, has regained its status as a fully reporting SEC current filer—marking a key milestone as it continues to revolutionize audience targeting across digital platforms. Known for eliminating bots and irrelevant impressions, Specificity’s proprietary ad tech delivers precision-targeted ads across display, social, and Connected TV (CTV) to the same verified, high-intent audiences —maximizing ROI and minimizing waste.
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) shares are up Tuesday following news that the company received a conditional extension from the Nasdaq Stock Market to regain compliance with listing standards.
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Power Metallic Mines Inc. (TSXV: PNPN, OTCQB: PNPNF ) has reached a historic milestone by securing the largest exploration license in Saudi Arabia’s Jabal Sayid Belt , marking a major step in the company’s global expansion strategy. The awarded Jabal Baudan project spans over 200 square kilometers , targeting copper, gold, and zinc in one of the Kingdom’s most mineral-rich regions.
